Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Bio Key International (BKYI) over the last 16 years, with Q3 2025 value amounting to $1325.0.

  • Bio Key International's Capital Expenditures fell 9374.35% to $1325.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2627.0, marking a year-over-year decrease of 11092.44%. This contributed to the annual value of $13047.0 for FY2024, which is 120470.0% up from last year.
  • Per Bio Key International's latest filing, its Capital Expenditures stood at $1325.0 for Q3 2025, which was down 9374.35% from $1478.0 recorded in Q2 2025.
  • Bio Key International's Capital Expenditures' 5-year high stood at $50974.0 during Q4 2022, with a 5-year trough of -$10000.0 in Q4 2024.
  • Moreover, its 5-year median value for Capital Expenditures was $4459.0 (2022), whereas its average is $9698.9.
  • Per our database at Business Quant, Bio Key International's Capital Expenditures surged by 113095.87% in 2022 and then plummeted by 110000.0% in 2024.
  • Quarter analysis of 5 years shows Bio Key International's Capital Expenditures stood at $4141.0 in 2021, then soared by 1130.96% to $50974.0 in 2022, then plummeted by 98.04% to $1000.0 in 2023, then tumbled by 1100.0% to -$10000.0 in 2024, then surged by 113.25% to $1325.0 in 2025.
  • Its last three reported values are $1325.0 in Q3 2025, $1478.0 for Q2 2025, and $4570.0 during Q1 2025.